Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bosse

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Blood|April 15, 1997
Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sitesC L Ramos, E J Kunkel, M B Lawrence, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
<i>BARD1</i> germline variants induce haploinsufficiency and DNA repair defects in neuroblastomaMichael P Randall, Laura E Egolf, Zalman Vaksman, et al.
Journal of the National Cancer Institute|September 9, 2023
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastomaMichael P Randall, Laura E Egolf, Zalman Vaksman, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T CellsGuillem Pascual-Pasto, Brendan McIntyre, Anna M Giudice, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cellsAnna Maria Giudice, Sydney L Roth, Stephanie Matlaga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Blood|April 15, 1997
Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sitesC L Ramos, E J Kunkel, M B Lawrence, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
<i>BARD1</i> germline variants induce haploinsufficiency and DNA repair defects in neuroblastomaMichael P Randall, Laura E Egolf, Zalman Vaksman, et al.
Journal of the National Cancer Institute|September 9, 2023
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastomaMichael P Randall, Laura E Egolf, Zalman Vaksman, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T CellsGuillem Pascual-Pasto, Brendan McIntyre, Anna M Giudice, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cellsAnna Maria Giudice, Sydney L Roth, Stephanie Matlaga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Pageof 6